DEXCEL PHARMA
Dexcel Pharma is Israelโs largest private pharmaceutical company. Founded in 1968, they develop, manufacture and market value-added branded and generic pharmaceuticals. With a diverse product portfolio that spans more than 55 branded and generic products in over 140 dosage forms, our products are sold in the US, the UK, and Germany, via subsidiaries and through a trusted network of partners in more than 30 countries worldwide.
DEXCEL PHARMA
Industry:
Health Care Manufacturing Medical Pharmaceutical
Founded:
1968-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.dexcel.com
Total Employee:
501+
Status:
Active
Contact:
+972046364000
Email Addresses:
[email protected]
Technology used in webpage:
SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Domain Not Resolving Wordpress Plugins Nginx
Similar Organizations
Gebro Pharma
Gebro Pharma is a developed into an internationally significant pharmaceutical company.
Martindale Pharma
Martindale Pharma is an international specialty pharma company.
Current Employees Featured
Ilan Oren
Ilan Oren Vice President, Business Development @ Dexcel Pharma Vice President, Business Development
Tzuki Harush
Tzuki Harush Vice President, Finance and Chief Financial Officer @ Dexcel Pharma Vice President, Finance and Chief Financial Officer
Dan Oren
Dan Oren Founder, President & Chief Executive Officer @ Dexcel Pharma Founder, President & Chief Executive Officer
Tomer Gold
Tomer Gold Vice President, Research & Development @ Dexcel Pharma Vice President, Research & Development
Uri Oren
Uri Oren Vice President, Chief Operating Officer @ Dexcel Pharma Vice President, Chief Operating Officer
Ygal Seelenfreund
Ygal Seelenfreund Vice President, Sales & Marketing, International @ Dexcel Pharma Vice President, Sales & Marketing, International
Founder
Dan Oren
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-05-16 | Kriya Therapeutics | Dexcel Pharma investment in Series C - Kriya Therapeutics | 270 M USD |
2021-08-16 | BrainQ | Dexcel Pharma investment in Venture Round - BrainQ | 40 M USD |
2021-07-14 | Kriya Therapeutics | Dexcel Pharma investment in Series B - Kriya Therapeutics | 100 M USD |
2021-02-11 | Immunai | Dexcel Pharma investment in Series A - Immunai | 60 M USD |
2020-05-12 | Kriya Therapeutics | Dexcel Pharma investment in Series A - Kriya Therapeutics | 80.5 M USD |
2018-11-13 | Roivant Sciences | Dexcel Pharma investment in Private Equity Round - Roivant Sciences | 200 M USD |
2014-05-01 | Roivant Sciences | Dexcel Pharma investment in Private Equity Round - Roivant Sciences | 93 M USD |
Official Site Inspections
http://www.dexcel.com Semrush global rank: 6.75 M Semrush visits lastest month: 819
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
Loading ...